GT
IHE icon

Glenmede Trust’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Glenmede Trust’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-153
Closed -$7K – 2705
2015
Q3 		$7K Hold
153
– – ﹤0.01% 2202
2015
Q2 		$8K Buy
+153
New +$8.94K ﹤0.01% 2145

Other funds holding IHE

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
AWA
ARS Wealth Advisors St. Petersburg, Florida $556M AUM 30.03% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
SFI
SPC Financial Inc Rockville, Maryland $1.28B AUM 12.6% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Glenmede Trust's IHE Position: Q4 2015 in Review

Glenmede Trust sold out of iShares US Pharmaceuticals ETF (IHE) in Q4 2015, closing a stake of 153 shares — an estimated $7K sold.

Glenmede Trust first reported a position in IHE in Q2 2015 and held it in 2 quarters. The position peaked at $8K in Q2 2015. 103 funds tracked by Wall St. Rank hold IHE as of Q4 2015.

  • Glenmede Trust reported no remaining iShares US Pharmaceuticals ETF position as of Q4 2015 after selling out during the quarter.
  • Glenmede Trust sold 153 iShares US Pharmaceuticals ETF shares in Q4 2015, an estimated $7K.
  • Glenmede Trust first reported a position in iShares US Pharmaceuticals ETF in Q2 2015 and held it in 2 quarters.
  • Glenmede Trust's iShares US Pharmaceuticals ETF position peaked at $8K in Q2 2015.
  • 103 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q4 2015.

Based on Glenmede Trust's 13F filing for Q4 2015, filed 11 Feb 2016.